Pain Relief Ointment in pharma franchise in Kochi

Pain Relief Ointment in PCD pharma franchise in Tirupati

Pain Relief Ointment in top pharma company in Mysore

Pain Relief Ointment in pcd pharma supplier in Amritsar

Pain Relief Ointment in phama franchise company in India
Pain Relief Ointment in phama distributor in Kohima

Home/Products /etoricoxib-10mg-linseed-oil-30mg-menthol-50mg-methyl-salicylate-100mg-ointment

Etoscrib Gel Ointment

Composition : Etoricoxib (10mg) + Linseed Oil (30mg) + Menthol (50mg) + Methyl Salicylate (100mg)

Dosage Form : Ointment

Packaging Type : pack

Packaging : 50gm

Price : ₹175/-

Etoscrib Gel Ointment is a topical formulation designed to provide targeted relief for pain and inflammation. It combines four active ingredients: Etoricoxib (10mg), Linseed Oil (30mg), Menthol (50mg), and Methyl Salicylate (100mg), each contributing to its effectiveness. This unique combination works synergistically to reduce pain, swelling, and discomfort in localized areas.

Etoricoxib, a selective COX-2 inhibitor, helps to reduce inflammation and pain at the site of application. By inhibiting the COX-2 enzyme, Etoricoxib helps minimize the production of pro-inflammatory prostaglandins, providing relief from conditions such as arthritis and musculoskeletal pain.

Linseed Oil acts as a soothing emollient, helping to hydrate and soften the skin, while also enhancing the absorption of the active ingredients. Menthol creates a cooling sensation, which can help alleviate muscle and joint discomfort by providing temporary relief and reducing the sensation of pain. Methyl Salicylate, a common compound found in topical pain relievers, works by acting as a mild analgesic and counterirritant, producing a warming effect to help ease muscle stiffness and aches.

Together, these ingredients make Etoscrib Gel Ointment effective for managing localized pain from conditions like osteoarthritis, muscle strains, and minor joint pain. It is easy to apply directly to the affected area, providing fast-acting, targeted relief.

Read More

About the Product

Etoscrib Gel Ointment is a topical formulation designed to provide targeted relief for pain and inflammation. It combines four active ingredients: Etoricoxib (10mg), Linseed Oil (30mg), Menthol (50mg), and Methyl Salicylate (100mg), each contributing to its effectiveness. This unique combination works synergistically to reduce pain, swelling, and discomfort in localized areas.

Etoricoxib, a selective COX-2 inhibitor, helps to reduce inflammation and pain at the site of application. By inhibiting the COX-2 enzyme, Etoricoxib helps minimize the production of pro-inflammatory prostaglandins, providing relief from conditions such as arthritis and musculoskeletal pain.

Linseed Oil acts as a soothing emollient, helping to hydrate and soften the skin, while also enhancing the absorption of the active ingredients. Menthol creates a cooling sensation, which can help alleviate muscle and joint discomfort by providing temporary relief and reducing the sensation of pain. Methyl Salicylate, a common compound found in topical pain relievers, works by acting as a mild analgesic and counterirritant, producing a warming effect to help ease muscle stiffness and aches.

Together, these ingredients make Etoscrib Gel Ointment effective for managing localized pain from conditions like osteoarthritis, muscle strains, and minor joint pain. It is easy to apply directly to the affected area, providing fast-acting, targeted relief.

Potential side effects may include skin irritation, redness, or a mild burning sensation at the site of application.

Etoscrib Gel Ointment is indicated for localized pain relief in conditions like osteoarthritis, muscle pain, joint pain, and inflammation.

For external use only. Avoid contact with eyes, mucous membranes, and broken skin. Discontinue use if irritation occurs.

Store at room temperature, away from moisture and heat. Keep the lid tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation